We are live on ! Find out more
KRRO icon

Korro Bio

64 hedge funds and large institutions have $286M invested in Korro Bio in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

42% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 12

31% more funds holding

Funds holding: 4964 (+15)

4.84% more ownership

Funds ownership: 86.16%91% (+4.8%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

54% less capital invested

Capital invested by funds: $619M → $286M (-$333M)

Holders
64
Holders Change
+15
Holders Change %
+30.61%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
26
Increased
17
Reduced
12
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$38.5M +$987K +17,857 +2%
NMC
2
NEA Management Company
Maryland
$36.9M +$987K +17,857 +2%
DTC
3
Deep Track Capital
Connecticut
$26.1M +$42.6M +770,645 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$21.6M -$4.87M -88,080 -12%
Citadel Advisors
5
Citadel Advisors
Florida
$17.9M -$387 -7 -0%
EAM
6
Eventide Asset Management
Massachusetts
$17.9M -$461K -8,335 -2%
Vanguard Group
7
Vanguard Group
Pennsylvania
$15.9M +$11.1M +201,636 +76%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$15.4M +$10.5M +190,259 +72%
AG
9
Artal Group
Luxembourg
$14M -$340K -6,154 -1%
BlackRock
10
BlackRock
New York
$13.8M +$18M +325,760 +404%
QUSVM
11
Qiming U.S. Ventures Management
Washington
$12.5M
7IH
12
72 Investment Holdings
Connecticut
$9.38M
CAM
13
Cormorant Asset Management
Massachusetts
$9M -$14.6M -263,344 -50%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.73M +$4.5M +81,417 +140%
Verition Fund Management
15
Verition Fund Management
Connecticut
$4.15M -$978K -17,707 -13%
DCM
16
Driehaus Capital Management
Illinois
$3.96M +$6.46M +116,858 New
GTC
17
Ghost Tree Capital
New York
$3.39M +$5.53M +100,000 New
State Street
18
State Street
Massachusetts
$3.38M +$4.52M +81,788 +452%
Millennium Management
19
Millennium Management
New York
$2.85M +$1.29M +23,307 +38%
TLP
20
Tri Locum Partners
New York
$2.42M +$3.95M +71,428 New
ECM
21
ExodusPoint Capital Management
New York
$1.89M +$830K +15,026 +37%
SSA
22
Schonfeld Strategic Advisors
New York
$1.37M +$2.23M +40,303 New
RSCM
23
Rock Springs Capital Management
Maryland
$1.21M +$1.97M +35,719 New
HF
24
HRT Financial
New York
$1.1M +$1.8M +32,524 New
Walleye Capital
25
Walleye Capital
New York
$1M +$1.63M +29,534 New

KRRO Hedge Fund Activity: Q2 2024 in Review

64 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2024, worth a combined $286M — down 54% from $619M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new KRRO positions and 11 closed out — a net gain of 15 holders — while 17 added to existing stakes and 12 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $42.6M. The largest seller was Cormorant Asset Management, cutting an estimated $14.6M.

  • 64 institutional investors held Korro Bio (KRRO) as of Q2 2024, up from 49 in Q1 2024.
  • Funds reported $286M of Korro Bio stock for Q2 2024, down 54% quarter-over-quarter.
  • 26 funds opened new Korro Bio positions in Q2 2024 and 11 closed out, a net change of +15 holders.
  • The largest Korro Bio buyer in Q2 2024 was Deep Track Capital, an estimated $42.6M added.
  • The largest Korro Bio seller in Q2 2024 was Cormorant Asset Management, an estimated $14.6M sold.

Based on aggregated 13F filings for Q2 2024.